405 related articles for article (PubMed ID: 16339680)
41. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
[TBL] [Abstract][Full Text] [Related]
42. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
[TBL] [Abstract][Full Text] [Related]
43. Modern treatment of thalassaemia intermedia.
Borgna-Pignatti C
Br J Haematol; 2007 Aug; 138(3):291-304. PubMed ID: 17565568
[TBL] [Abstract][Full Text] [Related]
44. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease.
Angchaisuksiri P; Atichartakarn V; Aryurachai K; Archararit N; Chuncharunee S; Tiraganjana A; Rattanasiri S
Am J Hematol; 2007 Nov; 82(11):1001-4. PubMed ID: 17654509
[TBL] [Abstract][Full Text] [Related]
45. [Splenectomy in hereditary hemolytic anemia: 82 Tunisian cases].
Hafsia R; Zriba S; Gouider E; Ben Salah N; Borji W; Zaouche A
Tunis Med; 2009 May; 87(5):323-7. PubMed ID: 19927762
[TBL] [Abstract][Full Text] [Related]
46. Retrospective study of the incidence of portal vein thrombosis after splenectomy in hematological disorders: Risk factors and clinical presentation.
Sabbagh A; Keikhaei B; Joorabian M; Behzad MM; Momeni M
Blood Cells Mol Dis; 2019 Feb; 74():1-4. PubMed ID: 30293687
[TBL] [Abstract][Full Text] [Related]
47. Splenectomy and chronic thromboembolic pulmonary hypertension.
Jaïs X; Ioos V; Jardim C; Sitbon O; Parent F; Hamid A; Fadel E; Dartevelle P; Simonneau G; Humbert M
Thorax; 2005 Dec; 60(12):1031-4. PubMed ID: 16085731
[TBL] [Abstract][Full Text] [Related]
48. [Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohort study].
Pouchain D; Bergmann JF; Bosson JL
Rev Prat; 2008 Dec; 58(19 Suppl):3-8. PubMed ID: 19253785
[TBL] [Abstract][Full Text] [Related]
49. Splenectomy is associated with hypercoagulable thrombelastography values and increased risk of thromboembolism.
Pommerening MJ; Rahbar E; Minei K; Holcomb JB; Wade CE; Schreiber MA; Cohen MJ; Underwood SJ; Nelson M; Cotton BA
Surgery; 2015 Sep; 158(3):618-26. PubMed ID: 26209572
[TBL] [Abstract][Full Text] [Related]
50. [Intermediate thalassemia: a new condition associated with hypercoagulability].
Mannucci PM
Ann Ital Med Int; 2000; 15(3):187-8. PubMed ID: 11059057
[No Abstract] [Full Text] [Related]
51. A mouse model to study thrombotic complications of thalassemia.
Kalish Y; Malyutin Z; Shai E; Dana M; Avraham L; Jahshan N; Rachmilewitz E; Fibach E; Varon D
Thromb Res; 2015 Mar; 135(3):521-5. PubMed ID: 25613926
[TBL] [Abstract][Full Text] [Related]
52. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
Lv RY; Wen FQ; Yu J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
[TBL] [Abstract][Full Text] [Related]
53. Aspirin resistance in children and young adults with splenectomized thalassemia diseases.
Sirachainan N; Wijarn P; Chuansumrit A; Kadegasem P; Wongwerawattanakoon P; Soisamrong A
Thromb Res; 2015 May; 135(5):916-22. PubMed ID: 25776469
[TBL] [Abstract][Full Text] [Related]
54. A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major.
Eldor A; Maclouf J; Lellouche F; Ben-Yashar V; Barenholz Y; Durst R; Hy-Am E; Goldfarb A; Rachmilewitz E
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():92-5. PubMed ID: 7886616
[TBL] [Abstract][Full Text] [Related]
55. Thrombocytosis following splenectomy: with or without additional organ resection.
Oida T; Kano H; Mimatsu K; Kawasaki A; Kuboi Y; Fukino N; Kida K; Amano S
Hepatogastroenterology; 2012 Jun; 59(116):1033-5. PubMed ID: 22580653
[TBL] [Abstract][Full Text] [Related]
56. Portal vein thrombosis after splenectomy for beta-thalassemia major.
Al-Hawsawi ZM; Haouimi AS; Hassan RA; Tarawah AM
Saudi Med J; 2004 Feb; 25(2):225-8. PubMed ID: 14968225
[TBL] [Abstract][Full Text] [Related]
57. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
[TBL] [Abstract][Full Text] [Related]
58. [Transfusion requirements and mean annual hemoglobin level in thalassemia major].
Brunengo MA; Girot R
Nouv Rev Fr Hematol (1978); 1986; 28(5):309-13. PubMed ID: 3808940
[TBL] [Abstract][Full Text] [Related]
59. Splenectomy and thrombosis: the case of thalassemia intermedia.
Taher AT; Musallam KM; Karimi M; El-Beshlawy A; Belhoul K; Daar S; Saned M; Cesaretti C; Cappellini MD
J Thromb Haemost; 2010 Oct; 8(10):2152-8. PubMed ID: 20546125
[TBL] [Abstract][Full Text] [Related]
60. Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
Klaihmon P; Phongpao K; Kheansaard W; Noulsri E; Khuhapinant A; Fucharoen S; Morales NP; Svasti S; Pattanapanyasat K; Chaichompoo P
Ann Hematol; 2017 Feb; 96(2):189-198. PubMed ID: 27900452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
